Systematic review: infliximab therapy in ulcerative colitis
JP Gisbert, Y Gonzalez‐Lama… - Alimentary pharmacology …, 2007 - Wiley Online Library
Aim To perform a systematic review and meta‐analysis on the efficacy and tolerance of
infliximab in ulcerative colitis. Methods Selection of studies: evaluating efficacy of infliximab …
infliximab in ulcerative colitis. Methods Selection of studies: evaluating efficacy of infliximab …
The quest for the function of simple epithelial keratins
DW Owens, EB Lane - Bioessays, 2003 - Wiley Online Library
Simple epithelial keratins K8 and K18 are components of the intracellular cytoskeleton in the
cells of the single‐layered sheet tissues inside the body. As members of the intermediate …
cells of the single‐layered sheet tissues inside the body. As members of the intermediate …
Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease
AM Smith, FZ Rahman, BH Hayee, SJ Graham… - Journal of Experimental …, 2009 - rupress.org
The cause of Crohn's disease (CD) remains poorly understood. Counterintuitively, these
patients possess an impaired acute inflammatory response, which could result in delayed …
patients possess an impaired acute inflammatory response, which could result in delayed …
Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease
D Hommes, B Van Den Blink, T Plasse, J Bartelsman… - Gastroenterology, 2002 - Elsevier
BACKGROUND & AIMS:: We investigated if inhibition of mitogen-activated protein kinases
(MAPKs) was beneficial in Crohn's disease. METHODS:: Inhibition of JNK and p38 MAPK …
(MAPKs) was beneficial in Crohn's disease. METHODS:: Inhibition of JNK and p38 MAPK …
Anti–tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner
ACW Vos, ME Wildenberg, M Duijvestein, AP Verhaar… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Anti–tumor necrosis factor (TNF) α antibodies are effective in
treating patients with Crohn's disease whereas soluble TNFα receptors have not shown …
treating patients with Crohn's disease whereas soluble TNFα receptors have not shown …
Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis
MD Grounds, JO Torrisi - The FASEB Journal, 2004 - Wiley Online Library
Necrosis of skeletal muscle fibers in the lethal childhood myopathy Duchenne muscular
dystrophy (DMD) results from defects in the cell membrane‐associated protein dystrophin …
dystrophy (DMD) results from defects in the cell membrane‐associated protein dystrophin …
A positive response to infliximab in Crohn disease: association with a higher systemic inflammation before treatment but not with-308 TNF gene polymorphism
Background: Two-thirds to three-fourths of patients with either refractory luminal or fistulizing
Crohn disease respond to infliximab treatment. The ability or inability to respond seems to …
Crohn disease respond to infliximab treatment. The ability or inability to respond seems to …
Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease
OBJECTIVES: The aim of this study was to assess the efficacy and safety of a single infusion
of infliximab in the treatment of pediatric Crohn's disease (CD). METHODS: A total of 21 …
of infliximab in the treatment of pediatric Crohn's disease (CD). METHODS: A total of 21 …
Prediction of antitumour necrosis factor clinical efficacy by real-time visualisation of apoptosis in patients with Crohn's disease
JMH Van den Brande, TC Koehler, Z Zelinkova… - Gut, 2007 - gut.bmj.com
Background: The human anti-tumour necrosis factor (TNF) antibody infliximab binds to the
membrane TNF and subsequently induces apoptosis of activated lamina propria T …
membrane TNF and subsequently induces apoptosis of activated lamina propria T …
Tissue cytokine and chemokine expression in inflammatory bowel disease
G McCormack, D Moriarty, DP O'Donoghue… - Inflammation …, 2001 - Springer
Objective and design: This study aimed to determine if mucosal expression of the
chemokines IL-8, RANTES and MCP-1 and the pro-inflammatory cytokines TNFα and IL-6 …
chemokines IL-8, RANTES and MCP-1 and the pro-inflammatory cytokines TNFα and IL-6 …